*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management
Recap: Bitcoin and the US markets are losing steam after rallying for the majority of the month of March. We entered
UVXY on 3/25/22 at $14.25 per share. Our take profit was set at $18.
My team has decided to average down on
UVXY at $11.75 per share which now brings our share average to $13. We have also added a 2nd take profit at $21.
SHARE AVERAGE: $13
TAKE PROFIT 1: $18
TAKE PROFIT 2: $21
If you want to see more, please like and follow us SimplyShowMeTheMoney
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management
Recap: Bitcoin and the US markets are losing steam after rallying for the majority of the month of March. We entered
My team has decided to average down on
SHARE AVERAGE: $13
TAKE PROFIT 1: $18
TAKE PROFIT 2: $21
If you want to see more, please like and follow us SimplyShowMeTheMoney
Note
We are conquerors. If you were able to buy in with us on 4/20/22 then congrats.Note
We missed our take profit 1 at $18 and were not able to sell in time. We are cancelling take profit 1 altogether and are preparing to sell our shares between $20-23. We are placing a stop profit loss at $14.25 so that we can at least walk away with some gains from this trade.Trade closed manually
We sold our shares today at $15.20 today. We tried to sell on Monday because we expected a bounce on Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.